Clinical Trials Directory

Trials / Completed

CompletedNCT06613321

Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy

Impact of Lung Hyperinflation on the Response to Pulmonary Vasodilator Therapy in Patients with Pulmonary Hypertension (PH) Associated with Chronic Obstructive Pulmonary Disease (COPD).

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this retrospective observational study is to evaluate if lung distension disorders can be a predictive factor of bad response to vasodilator therapy in patients with pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD). The study will include all patients from the hospital, followed for pulmonary hypertension associated with COPD under vasodilator therapy between 2015 and 2021.

Detailed description

The goal of this retrospective observational study is to evaluate if lung distension disorders can be a predictive factor of bad response to vasodilator therapy in patients with pulmonary hypertension (PH) associated with chronic obstructive pulmonary disease (COPD). The study will include all patients from the hospital, followed for PH associated with COPD under vasodilator therapy between 2015 and 2021. It will evaluate patients' lung hyperinflation according to the RV/TLC ratio and their response to treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRespiratory function tests before introduction of vasodilator therapyRespiratory function tests before introduction of vasodilator therapy with evaluation of the RV/TLC ratio.
DIAGNOSTIC_TEST3 month follow up evaluation of response to treatment.Follow up of patients at least 3 months after introduction of vasodilator therapy to determine response to treatment or absence of response.

Timeline

Start date
2023-08-01
Primary completion
2024-03-25
Completion
2024-03-25
First posted
2024-09-25
Last updated
2024-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06613321. Inclusion in this directory is not an endorsement.